New hope for advanced cancers? phase 1 trial launches
Disease control
Recruiting now
This early-stage study tests a new drug called IM-1021 in people with advanced solid tumors or lymphomas that have not responded to other treatments. The main goal is to check the drug's safety and find the best dose. About 117 adults will take part in this research.
Phase: PHASE1 • Sponsor: Immunome, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC